Clinical Study Results
Where can I learn more about this study?
You can find more information about this study on the websites listed below. If a full report
of the study results is available, it can also be found here.
• www.clinicaltrials.gov. Once you are on the website, type NCT02558894 into the
search box called “Other Terms”. Then, click “Search all studies”.
• www.clinicaltrialsregister.eu. Once you are on the website, click “Home and
Search”. Then, type 2015-002001-11 in the search box and click “Search”.
If you have questions about the results, please speak with the doctor, research nurse,
or other team member at your clinic or hospital.
For more details about your study, please also refer to the informed consent form you
signed before joining this study.
The full title of your study is: A Phase II Open-Label, Multi-Center Study of MEDI4736
Evaluated as Single Agent or in Combination with Tremelimumab in Patients with
Metastatic Pancreatic Ductal Adenocarcinoma
The protocol number of your study is: D4198C00001
AstraZeneca AB, the sponsor of this study, has its headquarters in Södertälje, Sweden.
The phone number for the AstraZeneca Information Center is 1-877-240-9479.
Thank you
Clinical study participants belong to a large community of people who take part in clinical
research around the world. They help researchers answer important health questions
and find medical treatments for participants. It takes participants in many studies all
around the world to advance medical science.
The Center for Information & Study on Clinical Research Participation (CISCRP) is a non-profit organization focused
on educating and informing the public about clinical research participation. CISCRP is not involved in recruiting
participants for clinical studies, nor is it involved in conducting clinical studies.
CISCRP • One Liberty Square, Suite 510 • Boston, MA 02109
1-877-MED-HERO • www.ciscrp.org
8
Version: V1.0 04/2018